BackRegencell Bioscience Holdings Overview

Regencell Bioscience Holdings Accounts Payable

Latest accounts payable for RGC: $0.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$0.00

Peer trimmed avg / median

Loading

Regencell Bioscience Holdings Accounts Payable History

Loading

Regencell Bioscience Holdings vs. peers: Accounts Payable Comparison

Loading

Regencell Bioscience Holdings Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Regencell Bioscience Holdings (RGC) FAQ

Regencell Bioscience Holdings (RGC) currently reports a accounts payable of $0 as of December 2025. In the prior-year period, the figure was $0. Use the charts on this page to explore Regencell Bioscience Holdings's accounts payable history and peer comparisons.

Regencell Bioscience Holdings's accounts payable changed from $0 to $0 (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Regencell Bioscience Holdings reported $0 in accounts payable as of December 2025. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Regencell Bioscience Holdings, and consider following RGC for alerts when major investors trade the stock.

Regencell Bioscience Holdings is classified in the Healthcare sector. On accounts payable, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing RGC with unrelated industries.